Back to CVE records
Medium 6.1Published Jun 3, 2026

CVE-2026-20233A vulnerability in the web-based user interface of Cisco Webex Meetings could have allowed an unauthenticated, remote attacker to conduct a cross-site scripting (XSS) attack.

Updated under an hour ago ()

Does this affect you?

It affects cisco webex_meetings. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

A vulnerability in the web-based user interface of Cisco Webex Meetings could have allowed an unauthenticated, remote attacker to conduct a cross-site scripting (XSS) attack. Cisco has addressed this vulnerability in the Webex Meetings service, and no customer action is needed. This vulnerability existed because of insufficient validation of user input. Prior to this vulnerability being addressed, an attacker could have exploited this vulnerability by persuading a user to follow a malicious link. A successful exploit could have allowed the attacker to execute arbitrary script code in the browser of the targeted user or access sensitive, browser-based information.

CVSS
6.1 MEDIUM (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
Weakness (CWE)
CWE-79
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
Not given
NVD analysis
Analyzed
Record last updated
Jul 22, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
cisco webex_meetings
cisco:webex_meetings
39.6.0; 39.7.0; 39.7.4; 39.7.7; 39.8.0; 39.8.2; 39.8.3; 39.8.4; and 48 more ranges
NVD

References

  • vendor-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.